Ultralife Corporation to Report Third Quarter Results on November 8, 2024
Ultralife (NASDAQ: ULBI) has scheduled its third quarter 2024 financial results release for November 8, 2024, before market opens. The delayed reporting accommodates the anticipated closing of Electrochem Solutions acquisition by end of October. Management will host an investor conference call and webcast at 8:30 AM ET on the same day. Pre-registration is required for phone participants through a provided link. A live webcast will be available on the company's website, with a replay accessible shortly after the call.
Ultralife (NASDAQ: ULBI) ha programmato la pubblicazione dei risultati finanziari del terzo trimestre 2024 per l'8 novembre 2024, prima dell'apertura del mercato. Il rinvio della comunicazione consente di gestire la chiusura prevista dell'acquisizione di Electrochem Solutions entro la fine di ottobre. La direzione ospiterà una conference call con gli investitori e una trasmissione in diretta alle 8:30 AM ET lo stesso giorno. È necessaria la registrazione anticipata per i partecipanti telefonici tramite un link fornito. Una trasmissione in diretta sarà disponibile sul sito web dell'azienda, con una registrazione accessibile poco dopo la chiamata.
Ultralife (NASDAQ: ULBI) ha programado el lanzamiento de sus resultados financieros del tercer trimestre de 2024 para el 8 de noviembre de 2024, antes de la apertura del mercado. El retraso en la presentación se ajusta al cierre anticipado de la adquisición de Electrochem Solutions para finales de octubre. La dirección llevará a cabo una llamada de conferencia para inversores y una transmisión web a las 8:30 AM ET el mismo día. Se requiere registrarse previamente para los participantes telefónicos a través de un enlace proporcionado. Una transmisión en vivo estará disponible en el sitio web de la empresa, con una repetición accesible poco después de la llamada.
Ultralife (NASDAQ: ULBI)는 2024년 11월 8일에 시장 개장 전에 2024년 3분기 재무 결과 발표를 예정하고 있습니다. 지연된 보고는 Electrochem Solutions 인수의 예상 종료에 맞추어 진행됩니다. 경영진은 같은 날 오전 8시 30분 ET에 투자자 컨퍼런스 콜 및 웹캐스트를 주최할 것입니다. 전화 참여자는 제공된 링크를 통해 사전 등록이 필요합니다. 회사 웹사이트에서 실시간 웹캐스트가 제공되며, 콜 직후에 재생이 가능해질 것입니다.
Ultralife (NASDAQ: ULBI) a prévu la publication de ses résultats financiers pour le troisième trimestre 2024 pour le 8 novembre 2024, avant l'ouverture du marché. Ce retard dans la publication permet de prendre en compte la clôture anticipée de l'acquisition de Electrochem Solutions d'ici la fin octobre. La direction organisera une conférence téléphonique avec les investisseurs et un webinaire à 8h30 ET le même jour. Une pré-inscription est nécessaire pour les participants par téléphone via un lien fourni. Un webinaire en direct sera disponible sur le site web de l'entreprise, avec une rediffusion accessible peu après l'appel.
Ultralife (NASDAQ: ULBI) hat die Veröffentlichung der Finanzzahlen für das dritte Quartal 2024 auf den 8. November 2024 vor der Markteröffnung angesetzt. Der verzögerte Bericht berücksichtigt den erwarteten Abschluss der Übernahme von Electrochem Solutions bis Ende Oktober. Das Management wird am gleichen Tag um 8:30 Uhr ET eine Investorenkonferenz und einen Webcast abhalten. Eine vorherige Registrierung für telefonische Teilnehmer ist über einen bereitgestellten Link erforderlich. Ein Live-Webcast wird auf der Website des Unternehmens verfügbar sein, mit einer Wiederholung die kurz nach dem Anruf zugänglich sein wird.
- Pending acquisition of Electrochem Solutions expected to close by October end
- None.
NEWARK, N.Y., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its third quarter results for the period ended September 30, 2024 before the market opens on Friday, November 8, 2024. The Company is reporting third quarter results later than its customary date after its quarter end in order to accommodate the expected closing of its acquisition of Electrochem Solutions, Inc. by the end of October.
Ultralife’s Management will also host an investor conference call and simultaneous webcast at 8:30 AM ET on November 8, 2024. Please see the call-in procedures which follow below.
NOTE TO THOSE PLANNING TO PARTICIPATE BY PHONE:
To ensure a fast and reliable connection to our investor conference call, we require participants dialing in by phone to pre-register using this link prior to the call: https://register.vevent.com/register/BI08b0baed0c3b4c4c932b669a039e555d. This will eliminate the need to speak with an operator. Once registered, dial-in information will be provided along with a personal identification number. Should you register early and misplace your details, you can simply click back on this same link at any time to register and view this information again.
A live webcast of the conference call will be available to investors in the Events & Presentations Section of the Company’s website at http://investor.ultralifecorporation.com. For those who cannot listen to the live broadcast, a replay of the webcast will be available shortly after the call at the same location.
About Ultralife Corporation
Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.
Headquartered in Newark, New York, the Company's business segments include: Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit http://www.ultralifecorporation.com.
| Company Contact: | Investor Relations Contact: |
| Ultralife Corporation | LHA |
| Philip A. Fain | Jody Burfening |
| (315) 210-6110 | (212) 838-3777 |
| pfain@ulbi.com | jburfening@lhai.com |
FAQ
When will Ultralife (ULBI) report Q3 2024 earnings?
Why is ULBI delaying its Q3 2024 earnings report?
How can investors access ULBI's Q3 2024 earnings call?
What acquisition is ULBI planning to complete in October 2024?
